In chronic active MS lesions, microglia adopt distinct transcriptional profiles, including lipid-phagocytic and iron-retentive subsets, marked by upregulated TREM2, APOE, and Complement C1q (C1Q) genes, which drive lipid metabolism, complement activation, and interferon responses (6, 8). The gene discussed is APOE; the disease is myeloid sarcoma.